Home/Pipeline/Cyto-MSC Knee Osteoarthritis

Cyto-MSC Knee Osteoarthritis

Knee Osteoarthritis

Phase 2Active

Key Facts

Indication

Knee Osteoarthritis

Phase

Phase 2

Status

Active

Company

MSC‑based cell therapy platform with halal‑certified products for Asia‑Pacific clinical markets.

Drug	Company	Phase	Status
Progenza	Cambium Bio	Phase 1/2a	Active
MAG200	Magellan	Phase 3	Active
MUTI™ Knee Replacement	Meril	Commercial	Active
DUROLANE	Bioventus	Commercial	Active
XSTEM	Xintela	Phase I/IIa	Completed (Results Reported)
Stempeucel®	Stempeutics Research	Commercial	Approved
Lipogems System for Knee Osteoarthritis	Lipogems International	Phase 3	Active
Signature Cord Prime™	Arugula Sciences	Phase 1	Active
Knee Osteoarthritis Study	Arizona Research Center	Not Specified	Active - Enrolling
4P004	4Moving Biotech	Phase 2a	Active
Lorecivivint (inferred)	Biosplice Therapeutics	Phase 3	Active
Regenerative Cell Therapy for Osteoarthritis	InGeneron	Phase 3	Active